Cytosolic prostaglandin e synthase: Expression patterns in control and alzheimer's disease brains

American Journal of Alzheimer's Disease and other Dementias

Volumn 24, Issue 1, 2009, Pages 46-51

  Chaudhry, Uzma A ^a   Dore, Sylvain ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase; Drug development; Eicosanoid; Human; Inflammation; Prostaglandin E2

Indexed keywords

PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; ISOMERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FRONTAL LOBE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; ASTROCYTE; CADAVER; CYTOLOGY; CYTOSOL; ENDOTHELIUM CELL; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; MIDDLE AGED; NERVE CELL; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; BRAIN; CADAVER; CYTOSOL; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICROGLIA; MIDDLE AGED; NEURONS; PYRAMIDAL CELLS;

EID: 63349087295     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317508323655     Document Type: Article

References (25)

1. Thornton E., Vink R., Blumbergs PC, Van Den Heuvel C. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 2006 ; 1094: 38-46. (Pubitemid 43927608)
2. Griffin WS, Liu L., Li Y., Mrak RE, Barger SW Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation. 2006 ; 3: 5.
3. Echeverria V., Clerman A., Dora© S. Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following A 2-amyloid exposure. Eur J Neurosci. 2005 ; 22: 2199-2206. (Pubitemid 41653533)
4. Tanioka T., Nakatani Y., Semmyo N., Murakami M., Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 2000 ; 275: 32775-32782.
5. Vazquez-Tello A., Fan L., Hou X., et al. Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain. Am J Physiol Regul Integr Comp Physiol. 2004 ; 287: R1155 - R1163. (Pubitemid 39391060)
6. Online Mendelian Inheritance in Man (OMIM). Prostaglandin E synthase 3. National Center for Biotechnology Information. Available at: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=607061. Accessed May 8, 2008.
7. Chaudhry U., Zhuang H., Crain BJ, Dora S. Elevated microsomal prostaglandin-Esynthase-1 in Alzheimer's disease. Alzheimers Dement. 2008. IN-PRESS.
8. Mirra SS, Heyman A., McKeel D., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991 ; 41: 479-486. (Pubitemid 19239715)
9. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991 ; 82: 239-259.
10. Tanaka Y., Furuyashiki T., Matsuoka T., Kitaoka S., Narumiya S. In Situ Hybridization Analyses of Cytosolic Prostaglandin E Synthase in Mouse Brains. Washington, DC: Society for Neuroscience ; 2005.
11. Hoozemans JJ, Rozemuller AJ, Janssen I., De Groot CJ, Veerhuis R., Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol (Berl). 2001 ; 101: 2-8. (Pubitemid 32124493)
12. Yermakova AV, O'Banion MK Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease. Neurobiol Aging. 2001 ; 22: 823-836. (Pubitemid 34066549)
13. Allen Brain Atlas [Internet]. Allen Institute for Brain Science. Available at: http://www.brain-map.org. Accessed May 8, 2008.
14. Maida ME, Hurley SD, Daeschner JA, Moore AH, Kerry O. 'banion M. Cytosolic prostaglandin E(2) synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease. Brain Res. 2006 ; 1103: 164-172. (Pubitemid 44080118)
15. Sang N., Zhang J., Marcheselli V., Bazan NG, Chen C. Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J Neurosci. 2005 ; 25: 9858-9870. (Pubitemid 41528023)
16. Hofacker A., Coste O., Nguyen HV, Marian C., Scholich K., Geisslinger G. Downregulation of cytosolic prostaglandin E2 synthase results in decreased nociceptive behavior in rats. J Neurosci. 2005 ; 25: 9005-9009. (Pubitemid 41384469)
17. Pickering G., Jourdan D., Dubray C. Acute versus chronic pain treatment in Alzheimer's disease. Eur J Pain. 2006 ; 10: 379-384.
18. Scherder E., van Manen F. Pain in Alzheimer's disease: nursing assistants' and patients' evaluations. J Adv Nurs. 2005 ; 52: 151-158. (Pubitemid 41392060)
19. Nakatani Y., Hokonohara Y., Kakuta S., Sudo K., Iwakura Y., Kudo I. Knockout mice lacking cPGES/p23, a constitutively expressed PGE2 synthetic enzyme, are perinatally lethal. Biochem Biophys Res Commun. 2007 ; 362: 387-392. (Pubitemid 47332420)
20. Combrinck M., Williams J., De Berardinis MA, et al. Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006 ; 77: 85-88. (Pubitemid 43022699)
21. Kobayashi T., Nakatani Y., Tanioka T., et al. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J. 2004 ; 381: 59-69. (Pubitemid 38932211)
22. Greenwood JA, Scott CW, Spreen RC, Caputo CB, Johnson GV Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. J Biol Chem. 1994 ; 269: 4373-4380. (Pubitemid 24237803)
23. Masliah E., Iimoto DS, Mallory M., Albright T., Hansen L., Saitoh T. Casein kinase II alteration precedes tau accumulation in tangle formation. Am J Pathol. 1992 ; 140: 263-268.
24. Amadoro G., Ciotti MT, Costanzi M., Cestari V., Calissano P., Canu N. NMDA receptor mediates tauinduced neurotoxicity by calpain and ERK/MAPK activation. Proc Natl Acad Sci U S A. 2006 ; 103: 2892-2897. (Pubitemid 43306645)
25. Angenstein F., Buchner K., Staak S. Age-dependent differences in glutamate-induced phosphorylation systems in rat hippocampal slices. Hippocampus. 1999 ; 9: 173-185. (Pubitemid 29196960)